The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Likhonos L.M.

FGBOU VO «Sankt-Peterburgskij gosudarstvennyj universitet», Sankt-Peterburg, Rossija, 199034

Smirnova I.O.

Sankt-Peterburgskiĭ gosudarstvennyĭ universitet, Sankt-Peterburg, Rossiia, 199106

Pustulosis palmaris et plantaris: pathogenetic, clinical, and epidemiological features

Authors:

Likhonos L.M., Smirnova I.O.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2017;16(3): 4‑12

DOI: 10.17116/klinderma20171634-12

Read: 58269 times

Download PDF (RU)
Contact the author
Table of contents

PUSTULOSIS PALMARIS ET PLANTARIS: PATHOGENETIC, CLINICAL, AND EPIDEMIOLOGICAL FEATURES
PUSTULOSIS PALMARIS ET PLANTARIS: PATHOGENETIC, CLINICAL, AND EPIDEMIOLOGICAL FEATURES

To cite this article:

Likhonos LM, Smirnova IO. Pustulosis palmaris et plantaris: pathogenetic, clinical, and epidemiological features. Russian Journal of Clinical Dermatology and Venereology. 2017;16(3):4‑12. (In Russ.)
https://doi.org/10.17116/klinderma20171634-12

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Pustulosis palmaris et plantaris is a rare chronic dermatosis characterized by formation of sterile pustules on the skin of palms and soles and torpid, relapsing course. Disease occurs mainly in middle-aged females and is strongly associated with smoking. Some authors consider pustulosis palmaris et plantaris as independent disease, while other still consider it as a form of psoriasis, using the previous term «Barber’s pustular psoriasis». The lack of consensus in the terminology and classification reflects ambiguity in pathogenesis of this dermatosis. When considering pustulosis in the context of psoriatic lesions, it is still unclear, why autoinflammatory response dominate over autoimmune. At the same time, the discovery of the role of mutations of IL-36(IL36RA) receptor antagonist gene in the development of some forms of generalized pustular psoriasis and Hallopeau acrodermatitis allowed some authors to refer pustulosis palmaris et plantaris as an autoinflammatory pustular neutrophilic dermatose. In this review, we collected and analyzed epidemiological, pathogenetic, and clinical data of different population studies of patients with palmoplantar pustulosis published in the recent literature.

Keywords:

pustulosis palmaris et plantaris
palmoplantar pustulosis
pustular psoriasis of palms and soles

Authors:

Likhonos L.M.

FGBOU VO «Sankt-Peterburgskij gosudarstvennyj universitet», Sankt-Peterburg, Rossija, 199034

Smirnova I.O.

Sankt-Peterburgskiĭ gosudarstvennyĭ universitet, Sankt-Peterburg, Rossiia, 199106

Close metadata

References:

  1. Pettey AA, Balkrishnan R, Rapp SR, Fleischer AB, Feldman SR. Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice. J Am Acad Dermatol. 2003;49(2):271-275.
  2. Yamamoto T. Extra-palmoplantar lesions associated with palmoplantar pustulosis. JEADV. 2009;(23):1227-1232. https:/doi.org/10.1111/j.1468-3083.2009.03296.x
  3. de Waal AC, van de Kerkhof PC. Pustulosis palmoplantaris is a disease distinct from psoriasis. J Dermatolog Treat. 2011;22(2):102-105. https:/doi.org/10.3109/09546631003636817
  4. Griffiths CE, Christophers E, Barker JN. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol. 2007;156:258. https:/doi.org/10.1111/j.1365-2133.2006.07675.x
  5. Ammoury A, El Sayed F, Dhaybi R, Bazex J. Palmoplantar pustulosis should not be considered as a variant of psoriasis. J Eur Acad Dermatol Venerol. 2008;22:392.https:/doi.org/10.1111/j.1468-3083.2007.02344.x
  6. Brunasso AM, Puntoni M, Aberer W, Delfino C, Francelli L, Massone C. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case-series study. Br J Dermatol. 2013;168:1243.https:/doi.org/10.1111/bjd.12223
  7. Farley E, Masrour S, McKey J, Menter A. Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool. J Am Acad Dermatol. 2009;60:1024-1031. https:/doi.org/10.1016/j.jaad.2008.11.910
  8. Robinson A, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Bebo BF Jr, Kalb RE. Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2012;67(2):279-288. https:/doi.org/10.1016/j.jaad.2011.01.032
  9. Asumalahti K, Ameen M, Suomela S, et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol. 2003;120(4):627-632. https:/doi.org/10.1046/j.1523-1747.2003.12094.x
  10. Murakami M, Ohtake T, Horibe Y, Ishida-Yamamoto A, Morhenn VB, Gallo RL, Iizuka H. Acrosyringium Is the Main Site of the Vesicle/Pustule Formation in Palmoplantar Pustulosis. Journal Invest Dermatol. 2010;130(8):2010-2016. https:/doi.org/10.1038/jid.2010.87
  11. Michaëlsson G, Kajermo U, Michaëlsson A, Hagforsen E. Infliximab can precipitate as well as worsen palmoplantar pustulosis: possible linkage to the expression of tumour necrosis factor-alpha in the normal palmar eccrine sweat duct? Br J Dermatol. 2005;153(6):1243-1244. https:/doi.org/10.1111/j.1365-2133.2005.06977.x
  12. Shmidt E, Wetter DA, Ferguson SB, Pittelkow MR. Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: the Mayo Clinic experience, 1998 to 2010. J Am Acad Dermatol. 2011;67(5):179-185. https:/doi.org/10.1016/j.jaad.2011.05.038
  13. Haley BN, Edward WC. Autoinflammatory Pustular Neutrophilic Diseases. Dermatol Clin. 2013;31(3):405-425. https:/doi.org/10.1016/j.det.2013.04.001
  14. Hagforsen E, Hedstrand H, Nyberg F, Michaëlsson G. Novel findings of Langerhans cells and interleukin-17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosis. Br J Dermatol. 2010;163(3):572-579. https:/doi.org/10.1111/j.1365-2133.2010.09819.x
  15. Khairutdinov VR, Samtsov AV, Moshkalov AV, Imyanitov EN. Sovremennye predstavleniya ob immunnykh mekhanizmakh razvitiya psoriaza (obzor literatury). Vestnik dermatologii i venerologii. 2007;1:3-6. (In Russ.).
  16. Christophers E, Metzler G, Röcke M. Bimodal Immune Activation in Psoriasis. Br J of Dermatol. 2014;170(1):59-65. https:/doi.org/10.1111/bjd.12631
  17. Cybulsky MI, Colditz IG, Movat HV. The role of interleukin-1 in Neutrophil Leukocyte Emigration Induced by Endotoxin. Am J Pathol. 1986;124(3):367-372.
  18. Smith EJ, Allantaz F, Bennett L, et al. Clinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review. Current Genomics 2010;11:519-527. https:/doi.org/10.2174/138920210793175921
  19. Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of Psoriasis. Annu Rev Immunol. 2014;32:227-255. https:/doi.org/10.1146/annurev-immunol-032713-120225
  20. Khader SA, Gaffen SL, Kolls JK. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol. 2009;2(5):403-411. https:/doi.org/10.1038/mi.2009.100
  21. Beer H, Contassot E, Lars E, French LE. The Inflammasomes in Autoinflammatory Diseases with Skin Involvement. J Invest Dermatol. 2014;134(7):1805-1810. https:/doi.org/10.1038/jid.2014.76
  22. Taylor PR, Roy S, Leal SM Jr, et al. Activation of neutrophils by autocrine IL-17A–IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2. Nature Immunology. 2014;15(2):143-151. https:/doi.org/10.1038/ni.2797
  23. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. IL-17, Produced by Lymphocytes and Neutrophils, Is Necessary for Lipopolysaccharide-Induced Airway Neutrophilia: IL-15 as a Possible Trigger. The Journal of Immunology. 2003;170(4):2106-2112.
  24. McKenna K, Beignon A, Bhardwaj N. Plasmacytoid Dendritic Cells: Linking Innate and Adaptive Immunity. J Virol. 2005;79(1):17-27. https:/doi.org/10.1128/JVI.79.1.17-27.2005
  25. Ko JM, Gottlieb AB, Kerbleski JF. Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases. J Dermatolog Treat. 2009;20(2):100-108. https:/doi.org/10.1080/09546630802441234
  26. Albanesi C. Heterogeneity of psoriasis and bimodal activation of local immune responses. Br J Dermatol. 2014;170(1):7-8. https:/doi.org/10.1111/bjd.12750
  27. Bissonnette R, Nigen S, Langley RG, Lynde CW, Tan J, Fuentes-Duculan J, Krueger JG. Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial. J Eur Acad Dermatol Venereol. 2014;28(10):1298-1305. https:/doi.org/10.1111/jdv.12272
  28. Kambe N, Nakamura Y, Iwasawa M, Matsue H. Autoinflammatory diseases and the inflammasome: mechanisms of IL-1β activation leading to neutrophil-rich skin disorders; Inflamation and regeneration. 2011;31(1):73-78.
  29. Abbas O, Itani S, Ghosn S, Kibbi AG, Fidawi G, Farooq M, Shimomura Y, Kurban M. Acrodermatitis continua of Hallopeau is a clinical phenotype of DITRA: evidence that it is a variant of pustular psoriasis. Dermatology. 2013;226(1):28-31. https:/doi.org/10.1159/000346572
  30. Setta-Kaffetzi N, Navarini AA, Patel VM, et al. Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes. J Invest Dermatol. 2013;133(5):1366-1369. https:/doi.org/10.1038/jid.2012.490
  31. Hüffmeier U, Wätzold M, Mohr J, Schön MP, Mössner R. Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations. Br J Dermatol. 2014;170(1):202-204. https:/doi.org/10.1111/bjd.12548
  32. Rossi-Semerano L, Piram M, Chiaverini C, De Ricaud D, Smahi A, Koné-Paut I. First clinical description of an infant with interleukin-36-receptor antagonist deficiency successfully treated with anakinra. Pediatrics. 2013;132(4):1043-1047. https:/doi.org/10.1542/peds.2012-3935
  33. Viguier M, Guigue P, Pagès C, Smahi A, Bachelez H. Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist Anakinra: lack of correlation with IL1RN mutations. Ann Intern Med. 2010;153(1):66-67. https:/doi.org/10.7326/0003-4819-153-1-201007060-00030
  34. Sugiura K, Takemoto A, Yamaguchi M, et al. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist. J Invest Dermatol. 2013;133(11):2514-2521. https:/doi.org/10.1038/jid.2013.230
  35. Wang TS, Chiu HY, Hong JB, Chan CC, Lin SJ, Tsai TF. Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients. Arch Dermatol Res. 2016;308(1):55-63. https:/doi.org/10.1007/s00403-015-1611-x
  36. Mössner R, Frambach Y, Wilsmann-Theis D, et al. Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14, but Not with Loss-of-Function Mutations in IL36RN in European Patients. J Invest Dermatol. 2015;135(10):2538-2541. https:/doi.org/10.1038/jid.2015.186
  37. Hellgren L, Mobacken H. Pustulosis palmaris et plantaris. Prevalence, clinical observations and prognosis. Acta Derm Venereol. 1971;51:284.
  38. Hagforsen E, Edvinsson M, Nordlind K, Michaëlsson G. Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis. Br J Dermatol. 2002;146:383.
  39. Eriksson MO, Hagforsen E, Lundin IP, Michaëlsson G. Palmoplantar pustulosis: a clinical and immunohistological study. Br J Dermatol. 1998;138:390.
  40. Hagforsen E, Nordlind K, Michaëlsson G. Skin nerve fibres and their contacts with mast cells in patients with palmoplantar pustulosis. Arch Dermatol Res. 2000;292:269.
  41. Sáez-Rodríguez M, Noda-Cabrera A, Alvarez-Tejera S, et al. The role of psychological factors in palmoplantar pustulosis. J Eur Acad Dermatol Venereol. 2002;16:325.
  42. Takahara M. Clinical outcome of tonsillectomy for palmoplantar pustulosis and etiological relationship between palmoplantar pustulosis and tonsils. Adv Otorhinolaryngol. 2011;72:86. https:/doi.org/10.1159/000324618
  43. Kikuchi N, Yamamoto T. Dental infection as a triggering factor in palmoplantar pustulosis. Acta Derm Venereol. 2013;93:721. https:/doi.org/10.2340/00015555-1552
  44. Akiyama T, Seishima M, Watanabe H, et al. The relationships of onset and exacerbation of pustulosis palmaris et plantaris to smoking and focal infections. J Dermatol. 1995;22:930.
  45. Yanagi T, Shimizu T, Abe R, Shimizu H. Zinc dental fillings and palmoplantar pustulosis. Lancet. 2005;366:1050. https:/doi.org/10.1016/S0140-6736(05)67384-9
  46. Nakamura K, Imakado S, Takizawa M, et al. Exacerbation of pustulosis palmaris et plantaris after topical application of metals accompanied by elevated levels of leukotriene B4 in pustules. J Am Acad Dermatol. 2000;42:1021. https:/doi.org/10.1067/mjd.2000.104305
  47. Song H, Yin W, Ma Q. Allergic palmoplantar pustulosis caused by cobalt in cast dental crowns: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111(6):e8. https:/doi.org/10.1016/j.tripleo.2010.12.013
  48. Shelling ML, Vitiello M, Lanuti EL, et al. A Case of Palmoplantar Pustulosis Induced by Certolizumab Pegol: New Anti-TNF-alpha Demonstrates the Same Class Effect. J Clin Aesthet Dermatol. 2012;5(8):40.
  49. Brunasso AM, Laimer M, Massone C. Paradoxical reactions to targeted biological treatments: A way to treat and trigger? Acta Derm Venereol. 2010;90(2):183-185. https:/doi.org/10.2340/00015555-0777
  50. Marsland AM, Chalmers RJ, Hollis S, et al. Interventions for chronic palmoplantar pustulosis. Cochrane Database Syst Rev. 2006;25(1):CD001433. https:/doi.org/10.1002/14651858.CD001433.pub2
  51. Burden AD, Kemmett D. The spectrum of nail involvement in palmoplantar pustulosis. Br J Dermatol. 1996;134(6):1079-1082.
  52. Kundu BK, Naik AK, Bhargava S, Srivastava D. Diagnosing the SAPHO syndrome: a report of three cases and review of literature. Clin Rheumatol. 2013;32(8):1237. https:/doi.org/10.1007/s10067-013-2251-1
  53. Rosén K, Lindstedt G, Mobacken H, Nyström E. Thyroid function in patients with pustulosis palmoplantaris. J Am Acad Dermatol. 1988;19:1009.
  54. Giménez-García R, Sánchez-Ramón S, Cuellar-Olmedo LA. Palmoplantar pustulosis: a clinicoepidemiological study. The relationship between tobacco use and thyroid function. J Eur Acad Dermatol Venereol. 2003;17:276.
  55. Michaëlsson G, Kristjánsson G, Pihl Lundin I, Hagforsen E. Palmoplantar pustulosis and gluten sensitivity: a study of serum antibodies against gliadin and tissue transglutaminase, the duodenal mucosa and effects of gluten-free diet. Br J Dermatol. 2007;156:659. https:/doi.org/10.1111/j.1365-2133.2006.07725.x
  56. Weisenseel P, Kuznetsov AV, Ruzicka T, Prinz JC. Palmoplantar pustulosis is not inevitably associated with antigliadin antibodies. Br J Dermatol. 2007;156:1399. https:/doi.org/10.1111/j.1365-2133.2007.07908.x
  57. Hagforsen E, Michaëlsson K, Lundgren E, et al. Women with palmoplantar pustulosis have disturbed calcium homeostasis and a high prevalence of diabetes mellitus and psychiatric disorders: a case-control study. Acta Derm Venereol. 2005;85:225-232. https:/doi.org/10.1080/00015550510026587
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.